PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...

Days of Our Lives” star Suzanne Rogers revealed she’s in remission after battling stage 2 colorectal cancer over the summer.

Haystack MRD test detects minimal residual disease in stage 2 colorectal cancer patients post-surgery, using circulating tumor DNA (ctDNA) for less invasive monitoring. The FDA's breakthrough device ...

Suzanne Rogers, star of Days of Our Lives, is opening up about her cancer diagnosis earlier this year. The actress who plays Maggie Horton in the Peacock drama revealed she was diagnosed with stage 2 ...

It was only a few short weeks ago when Days of our Lives icon Suzanne Rogers revealed she had been given a cancer diagnosis ...

Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC), a small study finds. 1 Among patients treated, TNT achieved a 93.7% ...

In a licensing deal unveiled Monday, Lyell Immunopharma is handing over $40 million in cash and almost 2 million of its ...

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

“Days of Our Lives” icon Suzanne Rogers has announced that she was diagnosed with Stage 2 colorectal cancer and recently underwent treatment. Rogers, who has portrayed Salem staple Maggie Horton for ...